{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T01:21:52Z","timestamp":1790990512136,"version":"4.1.0"},"reference-count":43,"publisher":"Frontiers Media SA","content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"DOI":"10.3389\/fimmu.2017.01275","type":"journal-article","created":{"date-parts":[[2017,10,11]],"date-time":"2017-10-11T13:13:49Z","timestamp":1507727629000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":27,"title":["Vaccine Containing the Three Allelic Variants of the Plasmodium vivax Circumsporozoite Antigen Induces Protection in Mice after Challenge with a Transgenic Rodent Malaria Parasite"],"prefix":"10.3389","volume":"8","author":[{"given":"Alba Marina","family":"Gimenez","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luciana Chagas","family":"Lima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katia Sanches","family":"Fran\u00e7oso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Priscila M. A.","family":"Denapoli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raquel","family":"Panatieri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel Y.","family":"Bargieri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Michel","family":"Thiberge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chiara","family":"Andolina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francois","family":"Nosten","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laurent","family":"Renia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruth S.","family":"Nussenzweig","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Victor","family":"Nussenzweig","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rogerio","family":"Amino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mauricio M.","family":"Rodrigues","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irene S.","family":"Soares","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2017,10,11]]},"reference":[{"key":"B1","article-title":"World Malaria Report 2015","year":"2016"},{"key":"B2","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1186\/1475-2875-13-481","article-title":"Severe vivax malaria: a systematic review and meta-analysis of clinical studies since 1900","volume":"13","author":"Rahimi","year":"2014","journal-title":"Malar J"},{"key":"B3","doi-asserted-by":"crossref","first-page":"79","DOI":"10.4269\/ajtmh.2007.77.79","article-title":"Vivax malaria: neglected and not benign","volume":"77","author":"Price","year":"2007","journal-title":"Am J Trop Med Hyg"},{"key":"B4","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1016\/S1473-3099(09)70177-X","article-title":"Key gaps in the knowledge of Plasmodium vivax, a neglected human malaria parasite","volume":"9","author":"Mueller","year":"2009","journal-title":"Lancet Infect Dis"},{"key":"B5","doi-asserted-by":"publisher","first-page":"e1160","DOI":"10.1371\/journal.pntd.0001160","article-title":"Why is Plasmodium vivax a neglected tropical disease?","volume":"5","author":"Carlton","year":"2011","journal-title":"PLoS Negl Trop Dis"},{"key":"B6","doi-asserted-by":"publisher","first-page":"62","DOI":"10.4269\/ajtmh.16-0180","article-title":"Key knowledge gaps for Plasmodium vivax control and elimination","volume":"95","author":"Bassat","year":"2016","journal-title":"Am J Trop Med Hyg"},{"key":"B7","doi-asserted-by":"publisher","first-page":"7489","DOI":"10.1016\/j.vaccine.2015.09.060","article-title":"Development of vaccines for Plasmodium vivax malaria","volume":"33","author":"Mueller","year":"2015","journal-title":"Vaccine"},{"key":"B8","doi-asserted-by":"publisher","first-page":"2915","DOI":"10.1016\/j.vaccine.2015.12.074","article-title":"Status of vaccine research and development of vaccines for malaria","volume":"34","author":"Birkett","year":"2016","journal-title":"Vaccine"},{"key":"B9","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1038\/216160a0","article-title":"Protective immunity produced by the injection of x-irradiated sporozoites of Plasmodium berghei","volume":"216","author":"Nussenzweig","year":"1967","journal-title":"Nature"},{"key":"B10","doi-asserted-by":"publisher","first-page":"397","DOI":"10.4269\/ajtmh.1975.24.397","article-title":"Immunization of man against falciparum and vivax malaria by use of attenuated sporozoites","volume":"24","author":"Clyde","year":"1975","journal-title":"Am J Trop Med Hyg"},{"key":"B11","doi-asserted-by":"publisher","first-page":"90","DOI":"10.4161\/hv.6.1.9677","article-title":"From the circumsporozoite protein to the RTS, S\/AS candidate vaccine","volume":"6","author":"Cohen","year":"2010","journal-title":"Hum Vaccin"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2016.10.047","article-title":"Malaria vaccine: WHO position paper, January 2016 \u2013 recommendations","year":"2017","journal-title":"Vaccine"},{"key":"B13","doi-asserted-by":"publisher","first-page":"2596","DOI":"10.1056\/NEJMe1606007","article-title":"Implementation of RTS,S\/AS01 malaria vaccine \u2013 the need for further evidence","volume":"374","author":"Clemens","year":"2016","journal-title":"N Engl J Med"},{"key":"B14","doi-asserted-by":"publisher","first-page":"e3268","DOI":"10.1371\/journal.pntd.0003268","article-title":"Protective efficacy of a Plasmodium vivax circumsporozoite protein-based vaccine in Aotus nancymaae is associated with antibodies to the repeat region","volume":"8","author":"Yadava","year":"2014","journal-title":"PLoS Negl Trop Dis"},{"key":"B15","doi-asserted-by":"publisher","first-page":"815","DOI":"10.1126\/science.2414847","article-title":"Circumsporozoite protein of Plasmodium vivax: gene cloning and characterization of the immunodominant epitope","volume":"230","author":"Arnot","year":"1985","journal-title":"Science"},{"key":"B16","doi-asserted-by":"publisher","first-page":"973","DOI":"10.1126\/science.2672336","article-title":"Circumsporozoite protein heterogeneity in the human malaria parasite Plasmodium vivax","volume":"245","author":"Rosenberg","year":"1989","journal-title":"Science"},{"key":"B17","doi-asserted-by":"crossref","first-page":"16297","DOI":"10.1016\/S0021-9258(18)55295-9","article-title":"Wide distribution of the variant form of the human malaria parasite Plasmodium vivax","volume":"266","author":"Qari","year":"1991","journal-title":"J Biol Chem"},{"key":"B18","doi-asserted-by":"publisher","first-page":"780","DOI":"10.1016\/0140-6736(93)90559-Y","article-title":"Identification of Plasmodium vivax-like human malaria parasite","volume":"341","author":"Qari","year":"1993","journal-title":"Lancet"},{"key":"B19","doi-asserted-by":"publisher","first-page":"1485","DOI":"10.1093\/infdis\/168.6.1485","article-title":"Global occurrence of Plasmodium vivax-like human malaria parasite","volume":"168","author":"Qari","year":"1993","journal-title":"J Infect Dis"},{"key":"B20","doi-asserted-by":"publisher","first-page":"455","DOI":"10.4269\/ajtmh.1989.40.455","article-title":"Immunization of Saimiri sciureus boliviensis with recombinant vaccines based on the circumsporozoite protein of Plasmodium vivax","volume":"40","author":"Collins","year":"1989","journal-title":"Am J Trop Med Hyg"},{"key":"B21","doi-asserted-by":"publisher","first-page":"21","DOI":"10.4269\/ajtmh.2011.10-0110","article-title":"Preclinical vaccine study of Plasmodium vivax circumsporozoite protein derived-synthetic polypeptides formulated in montanide ISA 720 and montanide ISA 51 adjuvants","volume":"84","author":"Arevalo-Herrera","year":"2011","journal-title":"Am J Trop Med Hyg"},{"key":"B22","doi-asserted-by":"publisher","first-page":"35","DOI":"10.4269\/ajtmh.2011.09-0507","article-title":"Antibody-mediated and cellular immune responses induced in naive volunteers by vaccination with long synthetic peptides derived from the Plasmodium vivax circumsporozoite protein","volume":"84","author":"Arevalo-Herrera","year":"2011","journal-title":"Am J Trop Med Hyg"},{"key":"B23","doi-asserted-by":"publisher","first-page":"46482","DOI":"10.1038\/srep46482","article-title":"Rational development of a protective P. vivax vaccine evaluated with transgenic rodent parasite challenge models","volume":"7","author":"Salman","year":"2017","journal-title":"Sci Rep"},{"key":"B24","doi-asserted-by":"publisher","first-page":"1448","DOI":"10.1016\/j.vaccine.2008.12.027","article-title":"Process development for the production of an E. coli produced clinical grade recombinant malaria vaccine for Plasmodium vivax","volume":"27","author":"Bell","year":"2009","journal-title":"Vaccine"},{"key":"B25","doi-asserted-by":"publisher","first-page":"1177","DOI":"10.1128\/IAI.01667-06","article-title":"A novel chimeric Plasmodium vivax circumsporozoite protein induces biologically functional antibodies that recognize both VK210 and VK247 sporozoites","volume":"75","author":"Yadava","year":"2007","journal-title":"Infect Immun"},{"key":"B26","doi-asserted-by":"publisher","first-page":"6216","DOI":"10.1016\/j.vaccine.2013.10.041","article-title":"Comparison of the immune responses induced by soluble and particulate Plasmodium vivax circumsporozoite vaccine candidates formulated in AS01 in rhesus macaques","volume":"31","author":"Vanloubbeeck","year":"2013","journal-title":"Vaccine"},{"key":"B27","doi-asserted-by":"publisher","first-page":"e0004423","DOI":"10.1371\/journal.pntd.0004423","article-title":"Phase 1\/2a trial of Plasmodium vivax malaria vaccine candidate VMP001\/AS01B in malaria-naive adults: safety, immunogenicity, and efficacy","volume":"10","author":"Bennett","year":"2016","journal-title":"PLoS Negl Trop Dis"},{"key":"B28","doi-asserted-by":"publisher","first-page":"1418","DOI":"10.1128\/CVI.00312-13","article-title":"Immunogenicity of recombinant proteins consisting of Plasmodium vivax circumsporozoite protein allelic variant-derived epitopes fused with Salmonella enterica serovar typhimurium flagellin","volume":"20","author":"Leal","year":"2013","journal-title":"Clin Vaccine Immunol"},{"key":"B29","doi-asserted-by":"publisher","first-page":"793","DOI":"10.1128\/IAI.01410-13","article-title":"Immunogenicity of a prime-boost vaccine containing the circumsporozoite proteins of Plasmodium vivax in rodents","volume":"82","author":"Teixeira","year":"2014","journal-title":"Infect Immun"},{"key":"B30","doi-asserted-by":"publisher","first-page":"1296","DOI":"10.1128\/IAI.01169-13","article-title":"Invasion-inhibitory antibodies elicited by immunization with Plasmodium vivax apical membrane antigen-1 expressed in Pichia pastoris yeast","volume":"82","author":"Vicentin","year":"2014","journal-title":"Infect Immun"},{"key":"B31","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1590\/S0074-02762011000900021","article-title":"TLR5-dependent immunogenicity of a recombinant fusion protein containing an immunodominant epitope of malarial circumsporozoite protein and the FliC flagellin of Salmonella typhimurium","volume":"106","author":"Camacho","year":"2011","journal-title":"Mem Inst Oswaldo Cruz"},{"key":"B32","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1084\/jem.156.1.20","article-title":"Circumsporozoite proteins of human malaria parasites Plasmodium falciparum and Plasmodium vivax","volume":"156","author":"Nardin","year":"1982","journal-title":"J Exp Med"},{"key":"B33","doi-asserted-by":"publisher","first-page":"6132","DOI":"10.1016\/j.vaccine.2008.08.070","article-title":"New malaria vaccine candidates based on the Plasmodium vivax merozoite surface protein-1 and the TLR-5 agonist Salmonella typhimurium FliC flagellin","volume":"26","author":"Bargieri","year":"2008","journal-title":"Vaccine"},{"key":"B34","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1186\/s12936-015-0830-0","article-title":"The suitability of laboratory-bred Anopheles cracens for the production of Plasmodium vivax sporozoites","volume":"14","author":"Andolina","year":"2015","journal-title":"Malar J"},{"key":"B35","doi-asserted-by":"publisher","first-page":"e1002699","DOI":"10.1371\/journal.ppat.1002699","article-title":"Pathogen-induced proapoptotic phenotype and high CD95 (Fas) expression accompany a suboptimal CD8+ T-cell response: reversal by adenoviral vaccine","volume":"8","author":"Vasconcelos","year":"2012","journal-title":"PLoS Pathog"},{"key":"B36","doi-asserted-by":"publisher","first-page":"2882","DOI":"10.1128\/IAI.00461-13","article-title":"Development of a chimeric Plasmodium berghei strain expressing the repeat region of the P. vivax circumsporozoite protein for in vivo evaluation of vaccine efficacy","volume":"81","author":"Espinosa","year":"2013","journal-title":"Infect Immun"},{"key":"B37","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1186\/s12936-016-1348-9","article-title":"The biological function of antibodies induced by the RTS,S\/AS01 malaria vaccine candidate is determined by their fine specificity","volume":"15","author":"Chaudhury","year":"2016","journal-title":"Malar J"},{"key":"B38","doi-asserted-by":"publisher","first-page":"2357","DOI":"10.1084\/jem.20111171","article-title":"Synthetic double-stranded RNA induces innate immune responses similar to a live viral vaccine in humans","volume":"208","author":"Caskey","year":"2011","journal-title":"J Exp Med"},{"key":"B39","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1186\/s13071-016-1862-1","article-title":"A recombinant multi-antigen vaccine formulation containing Babesia bovis merozoite surface antigens MSA-2a1, MSA-2b and MSA-2c elicits invasion-inhibitory antibodies and IFN-gamma producing cells","volume":"9","author":"Gimenez","year":"2016","journal-title":"Parasit Vectors"},{"key":"B40","doi-asserted-by":"publisher","first-page":"7284","DOI":"10.1038\/s41598-017-07246-0","article-title":"Adjuvanting a viral vectored vaccine against pre-erythrocytic malaria","volume":"7","author":"Milicic","year":"2017","journal-title":"Sci Rep"},{"key":"B41","doi-asserted-by":"publisher","first-page":"4363","DOI":"10.1128\/IAI.73.7.4363-4369.2005","article-title":"Quantitative dynamics of Plasmodium yoelii sporozoite transmission by infected anopheline mosquitoes","volume":"73","author":"Medica","year":"2005","journal-title":"Infect Immun"},{"key":"B42","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1016\/j.pt.2016.12.011","article-title":"Theoretical implications of a pre-erythrocytic Plasmodium vivax vaccine for preventing relapses","volume":"33","author":"White","year":"2017","journal-title":"Trends Parasitol"},{"key":"B43","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1080\/21645515.2016.1225635","article-title":"From discovery to licensure, the adjuvant system story","volume":"13","author":"Garcon","year":"2017","journal-title":"Hum Vaccin Immunother"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"http:\/\/journal.frontiersin.org\/article\/10.3389\/fimmu.2017.01275\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,8,4]],"date-time":"2022-08-04T07:58:09Z","timestamp":1659599889000},"score":1,"resource":{"primary":{"URL":"http:\/\/journal.frontiersin.org\/article\/10.3389\/fimmu.2017.01275\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,10,11]]},"references-count":43,"alternative-id":["10.3389\/fimmu.2017.01275"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2017.01275","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,10,11]]},"article-number":"1275"}}